Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;643(8072):839-846.
doi: 10.1038/s41586-025-09182-w. Epub 2025 Jun 18.

In vivo mapping of mutagenesis sensitivity of human enhancers

Affiliations
Free article

In vivo mapping of mutagenesis sensitivity of human enhancers

Michael Kosicki et al. Nature. 2025 Jul.
Free article

Abstract

Distant-acting enhancers are central to human development1. However, our limited understanding of their functional sequence features prevents the interpretation of enhancer mutations in disease2. Here we determined the functional sensitivity to mutagenesis of human developmental enhancers in vivo. Focusing on seven enhancers that are active in the developing brain, heart, limb and face, we created over 1,700 transgenic mice for over 260 mutagenized enhancer alleles. Systematic mutation of 12-base-pair blocks collectively altered each sequence feature in each enhancer at least once. We show that 69% of all blocks are required for normal in vivo activity, with mutations more commonly resulting in loss (60%) than in gain (9%) of function. Using predictive modelling, we annotated critical nucleotides at the base-pair resolution. The vast majority of motifs predicted by these machine learning models (88%) coincided with changes in in vivo function, and the models showed considerable sensitivity, identifying 59% of all functional blocks. Taken together, our results reveal that human enhancers contain a high density of sequence features that are required for their normal in vivo function and provide a rich resource for further exploration of human enhancer logic.

PubMed Disclaimer

Conflict of interest statement

Competing interests: A.K. is on the scientific advisory board of SerImmune, AINovo, TensorBio and OpenTargets. A.K. was a scientific co-founder of RavelBio, a paid consultant with Illumina, was on the scientific advisory board of PatchBio and owns shares in DeepGenomics, Immunai, Freenome and Illumina. The other authors declare no competing interests.

Update of

References

    1. Long, H. K., Prescott, S. L. & Wysocka, J. Ever-changing landscapes: transcriptional enhancers in development and evolution. Cell 167, 1170–1187 (2016). - PubMed - PMC
    1. Kvon, E. Z. et al. Comprehensive in vivo interrogation reveals phenotypic impact of human enhancer variants. Cell 180, 1262–1271 (2020). - PubMed - PMC
    1. Lambert, S. A. et al. The human transcription factors. Cell 172, 650–665 (2018). - PubMed
    1. Fickett, J. W. Quantitative discrimination of MEF2 sites. Mol. Cell. Biol. 16, 437–441 (1996). - PubMed - PMC
    1. Gotea, V. et al. Homotypic clusters of transcription factor binding sites are a key component of human promoters and enhancers. Genome Res. 20, 565–577 (2010). - PubMed - PMC